AN OPEN METABOLIC CLINICAL TRIAL TO EVALUATE THE EFFECTS OF PROPRANOLOL

评估普萘洛尔效果的开放代谢临床试验

• 批准号: 7950795
• 负责人: RICHARD LIN
• 金额: $ 0.16万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7950795
• 关键词: Anti-Inflammatory Agents; Anti-inflammatory; Aspirin; Blood Pressure; Cachexia; Clinical Research; Clinical Trials; Combination Medication; Computer Retrieval of Information on Scientific Projects Database; Etodolac; Funding; Grant; Institution; Metabolic; Pharmaceutical Preparations; Propranolol; Research; Research Personnel; Resources; Source; Symptoms; United States National Institutes of Health; improved; research study; wasting

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine if a combination of medications might improve your symptom of wasting (cachexia). The medications you will take in this research study are Propranolol, which is a medication that is used to regulate blood pressure, and Etodolac, which is a non-steroidal anti-inflammatory drug, a medication that is similar to aspirin.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本研究的目的是确定药物组合是否可以改善您的消瘦症状（恶病质）。 您在本研究中将服用的药物是普萘洛尔（一种用于调节血压的药物）和依托度酸（一种非甾体抗炎药，一种类似于阿司匹林的药物）。